ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
2
views
0
references
Top references
cited by
1
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
2,109
similar
All similar
Record
: found
Abstract
: not found
Book
: not found
Clinical Commissioning Policy Statement: Treatment for Defined Patients with MDR-TB and XDR-TB Including Bedaquiline and Delamanid
Author(s):
Publication date:
2019
Read this book at
Bookmark
There is no author summary for this book yet. Authors can add summaries to their books on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Policy Perspectives
Data availability:
Comments
Comment on this book
Sign in to comment
Similar content
2,109
Comment on Delamanid susceptibility testing of Mycobacterium tuberculosis using the resazurin microtitre assay and the BACTEC™ MGIT™ 960 system
Authors:
Frank Imkamp
,
Peter Keller
,
Erik C. Böttger
Characterization of genomic variants associated with resistance to bedaquiline and delamanid in naive mycobacterium tuberculosis clinical strains.
Authors:
S Battaglia
,
A. Spitaleri
,
Andrea Cabibbe
…
Population pharmacokinetics of delamanid and its main metabolite DM‐6705 in patients with multidrug resistant tuberculosis
Authors:
L. Tanneau
See all similar
Cited by
1
P27 A challenging case of MDR TB infection following a holiday in India
Authors:
Jemima Horsley Downie
,
Catriona Macrae
,
Nicholas Kennedy
See all cited by